These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6344715

  • 21. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC.
    Ann Intern Med; 1972 Dec; 77(6):829-35. PubMed ID: 4566283
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis.
    Sabbour MS, Osman LM.
    Br J Dermatol; 1979 Feb; 100(2):113-25. PubMed ID: 85455
    [Abstract] [Full Text] [Related]

  • 23. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 24. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 26. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW, Jenkins PG, Shelf WD, Bloodworth JM, Burkholder PM.
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [Abstract] [Full Text] [Related]

  • 27. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 May; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

  • 28. Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
    Balow JE, Austin HA, Muenz LR, Joyce KM, Antonovych TT, Klippel JH, Steinberg AD, Plotz PH, Decker JL.
    N Engl J Med; 1984 Aug 23; 311(8):491-5. PubMed ID: 6749206
    [Abstract] [Full Text] [Related]

  • 29. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS, Bretscher PA.
    J Rheumatol Suppl; 1987 Jun 23; 14 Suppl 13():194-8. PubMed ID: 3302253
    [Abstract] [Full Text] [Related]

  • 30. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
    Chan TM, Tse KC, Tang CS, Lai KN, Li FK.
    Lupus; 2005 Jun 23; 14(4):265-72. PubMed ID: 15864912
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of lupus nephritis in children].
    Niaudet P.
    Arch Pediatr; 1999 Dec 23; 6(12):1312-21. PubMed ID: 10627904
    [Abstract] [Full Text] [Related]

  • 32. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus.
    Lehman TJ, Onel K.
    J Pediatr; 2000 Feb 23; 136(2):243-7. PubMed ID: 10657833
    [Abstract] [Full Text] [Related]

  • 33. Editorial: Diffuse proliferative lupus nephritis. Evaluation of therapy.
    McVicar MI, Smithwick EM, Friedman EA.
    Urology; 1973 Feb 23; 1(2):174-6. PubMed ID: 4589231
    [No Abstract] [Full Text] [Related]

  • 34. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
    Mok CC, Ying KY, Yim CW, Ng WL, Wong WS.
    Lupus; 2009 Oct 23; 18(12):1091-5. PubMed ID: 19762384
    [Abstract] [Full Text] [Related]

  • 35. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J, Li CW, Zhang X, Pi SH, Zhao JS, Chen XY, Liu Y.
    Zhonghua Er Ke Za Zhi; 2003 Jun 23; 41(6):430-4. PubMed ID: 14748998
    [Abstract] [Full Text] [Related]

  • 36. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug 23; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 37. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C, Karokis D, Liossis SC.
    Semin Arthritis Rheum; 2017 Jun 23; 46(6):788-790. PubMed ID: 27793432
    [Abstract] [Full Text] [Related]

  • 38. Effect of azathioprine on renal histology and function in lupus nephritis.
    Shelp WD, Bloodworth JM, Rieselbach RE.
    Arch Intern Med; 1971 Oct 23; 128(4):566-73. PubMed ID: 5111661
    [No Abstract] [Full Text] [Related]

  • 39. Lupus nephritis: long-term follow-up.
    Cameron JS, Jones MB.
    Perspect Nephrol Hypertens; 1973 Oct 23; 1 Pt 2(0):1187-91. PubMed ID: 4215066
    [No Abstract] [Full Text] [Related]

  • 40. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ, Choi SE, Xu H, Kang JH, Lee KE, Lee JS, Choi YD, Lee SS.
    Int J Rheum Dis; 2018 Feb 23; 21(2):458-467. PubMed ID: 29314776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.